Stock A203400 ABION INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Abion Inc.

Equities

A203400

KR7203400007

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
10,460 KRW -3.15% Intraday chart for Abion Inc. +25.72% +24.08%
2023 Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc. CI
2023 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 6 billion in funding from Abion Inc. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.
CI
TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 6 billion in funding from Abion Inc.
CI
Gencurix Inc. announced that it has received KRW 2 billion in funding from Abion Inc.
CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 6 billion in funding from Abion Inc.
CI
Gencurix Inc. announced that it expects to receive KRW 2 billion in funding from Abion Inc.
CI
Abion Inc. announced that it has received KRW 8.499991272 billion in funding
CI
Abion Inc. announced that it expects to receive KRW 8.499991272 billion in funding
CI
ABION Presents New Efficacy Data for ABN401
CI
Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others
CI
Abion Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Abion Inc. Auditor Raises 'Going Concern' Doubt
CI
Abion Inc. announced that it has received KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm
CI
Abion Inc. announced that it expects to receive KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm and other investors
CI
Abion Inc. announced that it has received KRW 7 billion in funding from Hanwha Investment & Securities Co., Ltd., MAGNA Investment Co., Ltd., Axis Investment Co., Ltd.
CI
Abion Inc. announced that it expects to receive KRW 7 billion in funding from Hanwha Investment & Securities Co., Ltd., MAGNA Investment Co., Ltd., Axis Investment Co., Ltd.
CI
TELCON RF PHARMACEUTICAL. Inc. acquired an additional 3.73% stake in Abion Inc. from Leeds Investments Inc. and an individual for KRW 2.8 billion.
CI
St-Stassets Health Care Fund No.1 cancelled the acquisition of an unknown stake in Abion Inc. from KPM TECH Co., Ltd.
CI
St-Stassets Health Care Fund No.1 and 27 other buyers acquired 32.04% stake in Abion Inc. from KPM TECH Co., Ltd. for KRW 24.4 billion.
CI
Abion Inc. announced that it has received KRW 8.999953 billion in funding
CI
Abion Inc. announced that it expects to receive KRW 8.999953 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A203400 Stock
  4. News Abion Inc.